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Prenatal diagnosis is now possible for junctional and recessive 
dystrophic forms of epidermolysis bullosa (EB) ; however, 
there is no similar published experience for dominant dystro-
phic EB, although data with KF-l monoclonal antibody sug-
gests that both forms of dystrophic EB can be identified at 
least postnatally with this unique probe. We now report our 
experience with light microscopy, electron microscopy, im-
munofluorescence mapping, and KF-l and LH 7:2monoclo-
nal antibodies, in both a mother with dominant dystrophic 
EB and her fetus at risk, and in a fetus previously shown to be 
affected with recessive dystrophic EB. KF-l and LH 7:2 anti-
gens were absent in recessive dystrophic EB fetal skin, identi-
cal to findings observed postnatally. LH 7:2 was normally 
expressed in a mother with dominant dystrophic EB and in 
her fetus at risk for this disease. In contrast, whi le KF-l 
A Pplication of recent technological advances to the study of normal human skin has led to a greater under-standing of the pathogenesis of various forms of in-herited epidermolysis bullosa (EB) [1]. In particular, the generation of polyclonal and monoclonal antibod-
ies specific for skin basement membrane has led to the discovery of 
several selective antigenic defects in ski n from patients with various 
forms ofEB [2-14] as well as the development of an indirect immu-
Manuscript received November 9,1987; accepted for publication April 6, 
1988 
Presented in part at the southern regional meeting of the American Feder-
ation of Clinical Research, New Orleans, LA, February 5, 1988 
Supported in part by the National Institute of Health (R23 AR 34861, 
SR01 AR 36629, & N01 AR 62271,JDF; HD 17664 & AR 21557, KAH); 
the Medical Research Service of the Veterans Administration ODF); and the 
Dllllhill Medical Trust (RAJE). 
Reprint requests to: Jo-David Fine, M.D., Department of Dermatology, 
University of Alabama at Birmingham, UAB Station, Box 76, Birmingham, 
Alabama 35294 
Abbreviation: EB: epidermolysis bullosa 
antigen was abnormally expressed in the affected mother, it 
was normally expressed in only 1/7 fetal biopsies despite the 
fact that this fetus was shown by light and electron micros-
copy and immuno.fluorescence mapping to be unaffected 
with dominant dystrophic EB. We conclude that 1) trans-
mission electron microscopy can be used to prenatally ex-
clude the diagnosis of dominant dystrophic EB (Cockayne-
Touraine variety), 2) immunofluorescence mapping is an 
accurate technique for prenatal as well as postnatal diagnosis 
of EB, and 3) KF-1 cannot by itself be used as an accurate 
probe for the prenatal diagnosis of dominant dystrophic EB, 
due to the arparent variability in the time for the normal 
expression 0 KF-1 in fetal skin during the second trimester. 
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nofluorescence technique ("mapping") [15 - 17] that permits rapid 
determination of the ultrastructural level of cleavage in such tissues. 
As a result, utilization of panels of several of these antibodies has 
allowed rapid and accurate postnatal diagnosis of each of the three 
types of EB, circumventing the need for electron microscopy in 
most situations. In addition, use of some of these antibodies provides 
add itional confirmation of certain subtypes (i.e., dominant vs. reces-
ive dystrophic EB, including localized forms of the latter) having 
similar or identical phenotypes during the neonatal period. 
Recently one of the authors (RAJE) has demonstrated that anti-
bodies to LH 7 :2, AA3, and GB3 can be successfully used to prena-
tally diagnose or exclude recessive dystrophic and junctional forms 
of EB, respectively [18,19]. Similar studies with KF-1 monoclonal 
antibody in dystrophic EB would be of potentially great importance 
because KF-l antigen is expressed by 16 weeks estimated gestational 
age in the normal developing fetus [20] and appears to be useful 
postnatally for the identification of both dominant and recessive 
forms of dystrophic EB. To date no other probes have been identi-
fied for dominant dystrophic disease nor has there been any pub-
lished experience with prenatal diagnosis in this subset of dys tro-
phic EB [21,22]. We have recently had the opportunity to examine 
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skin from both a mother with dominant dystrophic EB and her 
19.5-week-old fetus by light and electro n microscopy, immunoflu-
orescence mapping, and indirect immunoflu orescence with KF-1 
and LH 7:2 monoclonal antibodies. In addition , we now report our 
experience with KF-1 monoclonal antibody on skin from a 19 
week-old abortus previously shown to have recessive dystrophic 
EB. 
MATERIALS AND METHODS 
Case Histories 
Case 1: Case 1 was a 19 week-old fetus previously reported in 
greater detail and documented prenatally (by electron microscopy, 
immu nofluorescence mapping, and LH 7:2 monoclonal antibody) 
to have recessive dys trophic EB [1 8]. 
Case 2: Case 2 was an 19.5-week-old fetus at risk for dominant 
dystrophic EB. The mother, a 22 year-o ld primigravida, was fi rs t 
seen fo r evaluation during her fifteenth week of pregnancy. She 
gave a history of generalized bl ister formati on and mechanically 
fragi le skin since birth; healing was accompanied by the develop-
ment of atrophic scars. Although all skin surfaces were prone to 
blister, lesions tended to favor extensor surfaces of the extremities. 
Albopapuloid lesions were absent. Mucous membranes and other 
extracutaneous tissues were uninvolved, and the mother was of 
norma l body size and weight. N o other family members were 
known to have EB. Despite the latter the mother was felt clinicall y 
to have dominant dystrophic EB of the Cockayne-T ouraine variety 
(i.e., do mi nant dys trophic EB features in the absence of albopapu-
loid les ions [23,24]) ; as noted below, this impression was supported 
by electron microscopy, immunofluorescence mapping, and KF-1 
and LH 7:2 monoclonal antibody studies. 
O n the basis of the results of the studies to be described, the fetus 
in case 2 was beli eved to be unaffected and the mother chose to 
complete her pregnancy. She was full y advised as to the experimen-
tal nature of the use of these techniqu es for prenatal diagnosis and 
the uncertainty of their reliability in this setting. The mother deliv-
ered a normal term fe male baby; serial foll ow-up for over 15 months 
has revealed no clinical evidence of EB in this child. 
Source of Skin Specimens Skin biopsies were obtained via feto-
scopy in cases 1 and 2. In addition, a skin biopsy was obtained from 
the mother of case 2 during her fifth teenth week of pregnancy. 
Fetoscopy and Fetal Skin Biopsy Fetoscopy and fetal skin 
biopsy were performed at approximately 19 and 19. 5 gestational 
weeks in cases 1 and 2, respectively [25 - 28). N o blisters were visi-
ble on either fe tus. In case 2, fetal immobilization was achieved with 
intramuscular cura re. In case 1, fetal skin biopsies were obtained via 
di rect visualizati on of the fe tus. In case 2, ultrasound guided fetal 
skin biopsy was accomplished using an Acuson 128 with a 3.5 MHz 
sector transd ucer and an Olympus bronchial biopsy forceps, intro-
duced into the amniotic cavity th rough th e cannula of a Dyonics 
needlescope. For case 2, eight specimens were obtained from the 
fo ll owing sites: fo rearm (2), wris t (1) , thigh (2), knee (2), and abdo-
men (1) . In one specimen (wrist) , insufficient dermis was present for 
the specimen to be utilized for immunohistochemical studies. 
Initial H andling and Processing of Fetal Skin Specimens 
(Case 2) In the operatin g room each biopsy specimen was placed 
in to cold physiologic saline and then transported to a nearby labora-
tory (HKH) where it was sliced into smaller pieces under a dissect-
ing microscope. A portion of each specimen was placed into Mi-
chel's transport medium and transported by overni ght courier to 
another author's laboratory ODF), where each specimen was thor-
oughly rinsed in immunofluorescence transport buffer, embedded 
in OCT compoun d (Lab-Tek Products, N aperville, IL) , snap froze n 
in li quid ni trogen, and oriented on a cryostat fo r subsequent sec-
tion ing. Another portion was fixed overni ght in cold phosphate-
buffered 3% glu taraldehyde, postfixed for 1 h in phosphate-buffered 
1 % osmium tetroxide, and embedded in Araldite 502. Semi thin (0. 5 
micrometer) sections were stained wi th Pa rago n polychrome stain 
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and examined by light microscopy. Large thin sections were col-
lected on 200-mes h uncoated grids and on Formvar-coated slot 
grids, and examined us i ~,g a l EOL 100CX electron microscope. 
Another portion of each biopsy specimen was fixed in Zenker's 
fluid , embedded in Paraplas t, and studied by light microscopy. 
Antibodies and Reagents Utilized For immunofluorescence 
mapping, the following well-characteri zed antibodies were chosen: 
bullous pemphigoid autoantibody, sheep anti-human Iaminin and 
anti -human type IV collagen, and murine anti-human KF-l mono-
clonal antibody (the latter provided by Dr. Stephen 1. Katz, Na-
tional Cancer Institute, Beth esda, MD). Murine anti-human LH 7:2 
monoclonal antibody was the gift of Dr. Irene Leigh (Experimental 
Dermatology Laboratory, The London Hospital , London, En-
gland) . Fluorescein-conju gated second step antibodies (goat anti-
human IgG, rabbit anti-sheep IgG, rabbit anti-mouse IgG) were 
obtained from Cappel Laboratories (Cochranville, PA) and Dako-
patts (Mercia Brocades Ltd ., Surrey, England) . All antibody dilu-
tions were prepared in 0.0067 M phosphate buffered saline, pH 7.4 
(PBS). 
Immunofluorescence Mapping Studies Immunofluorescence 
mapping studies were performed on each of the seven technically 
adequate skin biopsy specimens fro m case two by an indirect immu-
nofluorescence technique previously described [4,5); in addition, as 
published elsewhere [18) , the specimen from case 1 was similarly 
examined. 
In brief, 6-Jlm-thick cryostat sections were prepared from each 
sa mple and mounted and air-dried on albuminized glass slides. Each 
ti ssue section was then incubated with primary polyclonal antibody 
(bullous pemphigoid autoancibody, 1:10; anti-laminin and anti-
type IV coll agen, 1 :40), rinsed with PBS, incubated with the spe-
cies-appropriate FITC-conjugated second step IgG, furth er rinsed 
in PBS, examined by epi-illumination with a Leitz Laborlux 12 
flu orescence microscope, and the results then photographically 
documented. . 
As negative serum controls, human and sheep sera were utilized 
in the same titers as those employed with matched hyperimmune 
sera. As tissue controls, normal adult human skin, neonatal foreskin, 
and a skin specimen from a normal 19-week-old human fetus were 
used in both immunoflourescence mapping and monoclonal anti-
body study protocols. 
KF- l and LH 7:2 Monoclonal Antibody Studies KF-l mono-
clonal antibody (in the form of murine ascites) was utilized undi-
luted and at 1:5, 1:10, and 1 :20 dilutions on each specimen (skins 
from fetuses in cases 1 and 2; skin from mother of case 2; control 
human skin; control 19-week-old fetus skin) . Non-hyperimmune 
mouse ascites, in identical dilutions, served as the negative control. 
Each specimen was incubated with the first step antibody, rinsed 
extensively in PBS. incubated with FITC-rabbit ami-mouse IgG, 
further rinsed in PBS, and examined as previously described. 
LH 7:2 monoclonal antibody study was performed in identical 
fashion except that the monoclonal antibody was used as undiluted 
supernatant and "spent" SP 2/0 supernatant served as its matched 
control. 
RESULTS 
Light and Electron Microscopy 
Case 1: Light and electron microscopy have been reported else-
where in case 1 (18), with findin gs consistent with recessive dystro-
phic EB. 
Case 2: Specimens for light and electron microscopy were obtained 
fro m two sites on the mother (lesional, knee; clinically unaffected 
skin, forearm) . In the former a small focus of dermal-epidermal 
separation was noted. Electron microscopy demonstrated this sepa-
ration to be beneath the level of the lamina densa (Fig lA). Well-
formed hemidesmosomes were present in normal numbers, asso-
ciated with fil aments traversing the lamina lucida. Fragments of 
anchoring fibril s remained attached to the lamina densa. N ear the 
focus of separation, poorly formed, rudimentary anchoring fibr ils 
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Figure 1. Electron microscopy from lesional skin of the affected mother (A) of case 2, demonstrating skin cleavage beneath the level of the lamina densa. At 
hi gher magnification (B) , rudimentary, poorly formed, anchoring fibril s (arrow) are visible in reduced numbers directly adjacent to the area of skin separation. 
In contrast, examination of all eight feta l skin biopsy samples from case 2 revea led intraepidennal (suprabasalar) foc i of separation (C). Higher magnification 
(D) of an area of unscparated feta l skin demonstrated the presence of wel l-formed hemidesmosomes and anchoring fibril s (arrow) in apparent normal 
numbers. Magnification bars: 1.0 (A,B,D) and 10 (D) micrometers. 
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were present in reduced number (Fig IB) . Adjacent skin, however, 
as well as skin from the unaffected forearm, had an apparently 
normal number of well-formed anchoring fibril s. 
Light microscopic examination of 8 fetal skin specimens from 
case 2 revealed foci of separation in all but two samples; some basal 
keratinocytes within each focus remained attached to the dermis. 
Electron microscopy revealed frequent foci of intra epidermal cleav-
age (Fig le). Well-formed hemidesmosomes and anchoring fibril s 
were present in apparent normal numbers (Fig ID). 
Immunofluorescence Mapping As previously reported [18] in 
case 1, anti-type IV collagen bound only the roof of the subepider-
mal blister, confirming sub-lamina densa cleavage . 
Findin gs in both the mother and fetus in case two are summarized 
in T able 1. In the mother, bullous pemphigoid antigen, laminin, and 
type IV collagen were all detected on the epidermal roof of an 
induced blister, consistent with sub-l amina densa cleavage (Fig 2A). 
In the fetus, bullous pemphigoid antigen, laminin, and type IV 
collagen were expressed along the dermoepidermal junction in 6/7, 
6/7, and 7/7 speci mens, respective! y. No subepidermal clefting was 
noted in any specimen, whereas large lower intraepidermal clefts 
were visualized in 4/7 specimens (Fig 2B) . 
KF-l and LH 7:2 Monoclonal Antibody Studies LH 7:2 
monoclonal antibody revealed absent binding in case 1. In contrast, 
normal binding was noted in each of seven skin biopsy specimens in 
case 2, when compared to simultaneously evaluated normal adult 
human skin. 
KF-l monoclonal antibody findings are summarized in Table II. 
N o binding was noted in case 1 (Fig 3A); in contras t, KF-l was 
detectable in skin from a simultaneously studied unaffected 19-
week-old fetus (Fig 3B). As noted in Table II, in the fetus in case 2, 
KF-l was variably expressed dependent upon the particular speci-
men examined. In some, KF-l antigen was either absent (Fig 4A) or 
present in apparent reduced amounts when compared to simulta-
neously studied control skin. In one fetal specimen,. however, ob-
tained from the forearm, the intensity ofKF-1monoclonal antibody 
binding was indistinguishable from that observed in simultaneously 
processed control ad ult human sk in (Fig4B, e). 
DISC USSION 
In this paper we describe the use of transmission electron micros-
copy and immunofluo rescence mapping technique for the at-
tempted prenatal diagnosis of the Cockayne-Touraine variant of 
dominant dystrophic EB, and of KF-l monoclonal antibody for 
prenatal diagnosis of both forms of dystrophic EB. Our present 
finding of absent KF-l binding in the skin of the fetus in case 1, 
previously documented to have recessive dystrophic EB, confirms 
that this monoclonal antibody may also be used in conjunction with 
electron microscopy in the prenatal diagnosis of this form of EB. 
In dominant dys trophic EB the only immunohistochemical 
probe currently available is KF-1. As previously published, KF-l 
antigen is present in much weaker intensity and/or detectabl e only 
at lower monoclonal antibody dilutions in skin from patients with 
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Figure 2. Immunofluorescence mapping of the affected mother (A) and 
fetus (B) from case 2, with anti-type IV coll agen; staining is confined to the 
roof (ar row) of the mother's skin, consistent w ith sub-lamina densa cleavage, 
wh ereas staining in the fetal skin is present exclusively along the base (aster-
isks denote clefts). Original magnifications: 250X (A); 400X (B) . 
Table 1. Immunofluorescence mapping findings in case 2 
Subject 
Mother 
Fetus 
• EPA: bullous pemphigoid antigen. 
b Sub-lamina densa cleavage in this specimen. 
, Large illtra-epidermal c1cft(s) presellt. 
Skin Site 
Arm 
Forearm 
Forearm 
Knee 
Knee 
Abdomen 
Thigh 
Thigh 
+ 
+ 
weak +, 
+ 
+ 
+ 
Laminin 
+" 
+c 
+ 
+c 
+ 
+ 
+ 
Expression of Basement 
Membrane Antigens 
Type IV Collagen 
+" 
+c 
+c 
+c 
+c 
+ 
+ 
weak + 
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Figure 3. KF-l antigen is absent in fetal skin from case 1 (A , opel/ arrolvs); in 
contrast, linear staining is noted in a simultaneously studied unaffected 19-
week-old fetus (B, arrow). Original magification: 400X (A, B) . 
dominant dystrophic EB. Originall y we reported seven cases with 
this form of dystrophic EB. Since then we have examined a total of 
19 cases of dominant dystrophic EB (all of the Cockayne-Touraine 
variety) with KF-l monoclonal antibody; in only one case has KF-l 
antigen been normally expressed. Thus it appears that skin speci-
mens from most cases of at least this particular subset of dominant 
dystrophic EB can be readily distin guished postnatally from those of 
normal controls and from patients with other forms of EB, when 
examined simultaneously with a series of stepwise dilutions of this 
monoclonal antibody. 
As noted in Tab le II, lack of concurrent immunofluorescence 
mapping and electron microscopy as well as fewer numbers of speci-
mens for examination with KF-l monoclonal antibody would have 
led to an incorrect diagnosis of dominant dystrophic EE in case 2, 
because KF- l findings in 6/7 were indistinguishable from those 
previously observed by one of the authors (JDF) postnatally in dys-
trophic disease [8]. Our correct determination in case 2 was based on 
the lack of detectable sub-lamina densa cleavage by both immuno-
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Figure 4. KF-t antigen was absent (A) or diminished along the dermocpi-
dermal junction (ope/! arrows) in most fetal specimens from case 2. In one 
sample (B): however, KF-l antigen appeared focally as intensely posi tive 
(arro ws) as was noted in control adult human skin (C) (arrows). Original 
magnifica tions: 360X (A): 400X (B, C). 
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Table II. KF-1 and LH 7: 2 monoclonal antibody findings 
KF-1 
Case Subject Skin Site LH 7:2 Neat 1:5 1 : 10 1 :20 
1 
2 
Fetus 
Mother 
Fetus 
Arm 
Forearm 
Forearm 
Knee 
Knee 
Abdomen 
Thigh 
, 
-
4+ wb 
4+ w, fd 
4+ 
4+ w 
4+ w 
4+ 
4+ w 
w w fae 
2+, f 2+, f 2+, f 
w 2+ wb 
1+ w 
w w w 
Thigh 2+, f 1+ 1+ 
• absent 
b w: weak 
, fa: faint 
d f: focal 
Normal adult skin 
(control) 
Normal fetal skin 
(control) 
Arm 
Arm 
fluorescence mapping and transmission electron microscopy, pres-
ence of apparent normal numbers of anchoring fibrils, and the pres-
ence of apparent normal amounts ofKF-1 antigen in 1/7 specimens. 
The abnormal expression of KF-1 in the remaining six specimens 
presumably reflects physiologic delays in antigen expression in 
some body regions, and suggests major potential problems with the 
use of this monoclonal antibody alone in prenatal diagnosis of either 
form of dystrophic EB. For example, it is especially disconcerting 
that KF-l antigen was normally expressed and absent in two speci-
mens, respectively, from adjacent areas on the left forearm; widely 
disparate interpretations can be made if the findings in only one of 
these two specimens is considered. W e would conclude, therefore , 
that KF-1 monoclonal antibody cannot be reliably used, by itself, 
prenatally to detect oftentimes subtle antigenic differences that are 
routinely .observed postnatally in skin from patients with dominant 
dystrophic EB. This is unfortunate because there is no other cur-
rently available means other than electron microscopy to prenatally 
diagnose this form of EB. In the case of recessive dystrophic EB, 
optimal information content can be derived from fetal skin biopsies 
by performing LH 7:2 monoclonal antibody studies in conjunction 
with electron microscopy and immunofluorescence mapping, be-
cause cl eavage planes may not be readily visible in every specimen 
from an affected fetus. Further confirmatory data may result from 
the concurrent performance of KF-1 monoclonal antibody studies, 
although the latter should be performed in conjunction with other 
diagnostic studies because false negative binding may occur with 
KF-1 in normal fetal skin in the 18-20-gestational-week period. 
As demonstrated in this study, immunofluorescence mapping 
may be a useful technique in the evaluation of prenatal as well as 
postnatal skin sampl es from individuals at risk for EB. In both pa-
tients we have noted excellent correlation between immunofluores-
cence mapping and electron microscopy of matched specimens, 
both in the presence (case 1) or absence (case 2) of basement mem-
brane cleavage. 
Finally, we were surprised to note at times rather large intraepi-
dermal clefts in 4/7 specimens from case 2; without prior knowl-
edge that the fetus was at risk for dominant dystrophic EB we might 
have inadvertently interpreted this finding as suggestive ofEB sim-
plex. We assume that these findings reflect some artifact induced 
during the course of fetal skin biopsy [29] because we have not 
observed these in neonatal or adult EB or normal skin as a result of 
brief tissue transportation in Michel's immunofluorescence buffer 
or physiologic saline, or as a result of routine fixation or embedding 
for either routine transmission electron microscopy or immunoflu-
orescence mapping studies. These findings do suggest, however, 
that additional care should be exercised in the interpretation of skin 
biopsies from fetuses at risk for EB simplex because artifactually 
positive intraepidermal cleavage may be possible in some specimens. 
4+ 
4+ 
2+ 2+ 2+ 2+ 
2+ 2+ 2+ 2+ 
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COMBINED WINTER SKIN SEMINAR 
This seminar will be held in Snowbird, Utah, March 4-11, 1989, and is sponsored by the 
Division of Dermatology at the University of Utah School of Medicine, and the Departments 
of Dermatology at the University of Colorado School of Medicine and U CLA School of 
M edicine. CME Category 1 credit has been requested. For further information colltact: Kath-
arine C. Blosch, Preferred Meeting Management, Inc., 640 E. Wilmington Ave. , Salt Lake 
City, Utah 84106 (Tel. 801/466-3500). 
